On September 18, the Final Competition and “Dual Recruitment and Dual Attraction” Promotion Conference of the 2026 Ji’an High-Level Talent Innovation and Entrepreneurship Competition was held in Shanghai. The event brought together outstanding science and technology innovation projects from across China, industry experts, investment institutions, government representatives, and business leaders.

Hunan Yineng Biotechnology & Pharmaceutical Co., Ltd. (Yineng Pharma) made its appearance at the competition final with its core innovation project, “Construction of a Full-Chain Innovation Platform for New Drugs Based on Ji’an Authentic Medicinal Materials and Classical Traditional Chinese Medicine (TCM) Formulas.”

With its advanced technological innovation, mature industrialization system, and strong overall performance during the competition, Yineng Pharma stood out among numerous participating teams and successfully won First Prize. The company’s project presentation and defense attracted considerable attention from guests, investment institutions, and industry professionals, making it one of the featured science and technology innovation projects of the competition.

A Platform Connecting Talent, Innovation, Investment, and Industrial Development

The 2026 Ji’an High-Level Talent Innovation and Entrepreneurship Competition serves as an important platform for attracting high-level talent, promoting the implementation of high-quality science and technology projects, and facilitating industrial investment and cooperation.

Through the innovation and entrepreneurship competition, the event established an integrated platform connecting talent exchange, project presentation, investment promotion, and government-business cooperation. It brought together high-quality innovation and entrepreneurship projects from different fields, providing opportunities for technology exchange, resource integration, and industrial collaboration.

During the final competition, Yineng Pharma presented its core project and systematically demonstrated the company’s technological innovations in digital and intelligent TCM research and development, core technical capabilities, market application potential, and clear plans for industrialization.

Full-Chain Innovation Platform for TCM New Drug Development

At the event, Yineng Pharma’s core innovation project, “Construction of a Full-Chain Innovation Platform for New Drugs Based on Ji’an Authentic Medicinal Materials and Classical TCM Formulas,” attracted extensive attention from government representatives, industry experts, investors, and other participants.

Supported by solid technological expertise, detailed data, and a clearly defined development strategy, the project demonstrated Yineng Pharma’s capabilities in TCM drug discovery, research and development, technology commercialization, and industrial cooperation.

During the subsequent on-site defense session, the Yineng Pharma team responded professionally and systematically to questions from the judges concerning technology iteration, market development, commercialization of research achievements, and industrial cooperation.

The team’s professional responses highlighted the company’s R&D capabilities, technical expertise, and innovation potential, receiving positive feedback from the expert judging panel and recognition from participants at the event.

Yineng Pharma: AI-Powered Innovation in Traditional Chinese Medicine

Yineng Pharma is a specialized and innovative enterprise that has undertaken multiple national-level science and technology projects. The company operates as a one-stop, full-process technology empowerment platform for the development and manufacturing of innovative TCM drugs in China.

With years of experience in digital and intelligent TCM innovation, Yineng Pharma focuses on the research, development, and commercialization of innovative TCM drugs, classical TCM formulas, and specialized TCM preparations.

The company has established standardized R&D platforms, comprehensive quality management systems, extensive experience in new drug development, and a highly qualified scientific research team. By continuously applying technological innovation to TCM research and development, Yineng Pharma aims to accelerate the modernization and intelligent transformation of the TCM industry and support high-quality innovation across the pharmaceutical sector.

Recognition of Yineng Pharma’s Innovation and Industrialization Capabilities

Winning First Prize in the competition represents recognition from the organizing committee and expert judges of Yineng Pharma’s technological innovation capabilities, project value, and overall team strength.

The achievement also demonstrates the company’s capabilities and development potential in the biopharmaceutical sector, particularly in the field of digital and intelligent TCM innovation. It is expected to further strengthen Yineng Pharma’s visibility and influence within the industry.

Going forward, Yineng Pharma will use this achievement as an opportunity to further strengthen technological innovation, accelerate the iteration and upgrading of scientific research achievements, and leverage the competition’s “Dual Recruitment and Dual Attraction” platform to deepen cooperation with governments, enterprises, investment institutions, and industry partners.

The company will continue to promote resource integration, industrial collaboration, and the commercialization of innovative research achievements, contributing to the innovation and high-quality development of the biopharmaceutical and TCM industries.

About Hunan Yineng Biotechnology & Pharmaceutical Co., Ltd.

Hunan Yineng Biotechnology & Pharmaceutical Co., Ltd. was founded by Dr. Yi Yueneng, a leading technology entrepreneur recognized under China’s National High-Level Talent Special Support Plan and a recipient of the Outstanding Achievement Award for Innovative Drugs from the China Pharmaceutical Development Award.

Yineng Pharma operates an AI + CXO pharmaceutical innovation technology platform, integrating artificial intelligence with pharmaceutical research and development capabilities.

As a specialized and innovative enterprise that has undertaken multiple national-level science and technology projects, the company has developed extensive capabilities in pharmaceutical innovation, R&D engineering, quality control, technology platforms, and commercialization.

AI + CXO Platform for Pharmaceutical Innovation

Yineng Pharma currently has a team of nearly 400 experienced R&D engineers, including academicians and leading scientific experts. The company has established approximately 20,000 square meters of digital and intelligent laboratories, representing an investment of more than RMB 200 million.

By applying AI technology throughout the TCM and natural medicine R&D process, Yineng Pharma aims to improve pharmaceutical innovation, optimize manufacturing processes, and accelerate the commercialization of scientific research achievements.

The company’s services cover more than 100 pharmaceutical enterprises and over 200 hospitals nationwide, providing one-stop, full-process technical suppo